Bone Neoplasm - Osteosarcoma

NCT00346164

Clinical Trial Information


Trial Number: NCT00346164 (ClinicalTrials.gov)
Disease Type:
  • Bone Neoplasm - Chondrosarcoma
  • Bone Neoplasm - Osteosarcoma
  • Miscellaneous Neoplasm - Vascular Tumor
  • Soft Tissue Neoplasm - Miscellaneous
  • Soft Tissue Neoplasm - Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Trial Title:
Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas in Patients Under 30 Years of Age
Study ID:
ARST0332
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00346164-D1 Dataset NCT00346164 -D1 is for recreating the results of the manuscript, which includes demographic and clinical characteristics, and survival outcomes. Each row corresponds with data from a single, unique patient.

NCT00716976

Clinical Trial Information


Trial Number: NCT00716976 (ClinicalTrials.gov)
Disease Type:
  • Bone Neoplasm - Osteosarcoma
  • CNS Neoplasm (Primary Tumor) - Embryonal Tumors
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Gastrointestinal Neoplasm - Liver and Hepatobiliary Cancer
  • Germ Cell Neoplasm - Miscellaneous
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children
Study ID:
ACCL0431
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT00716976-D3 NCT00716976-D3
One row for each of the 194 serious adverse events detailed on manuscript page 69. These events are reported through the National Cancer Institute, Cancer Therapy Evaluation Program, Adverse Event Reporting System (CTEP-AERS).
NCT00716976-D2 NCT00716976-D2
These data provide the incidence of toxicities. There is one record per patient-cycle. analysiset2=1 for rows included in Table 3 construction. analysiset3=1 for rows included in Table 4 construction.
NCT00716976-D1 NCT00716976-D1
There is one row for each patient enrolled. The first 14 variables are used to make Figure 1. Patients considered for analysis of study outcomes have the variable analysiset1=1. Variables 15-50 provide patient characteristics (Table 1), outcome (Figures 2 and 3) and hearing loss comparisons (Table 2).
Subscribe to Bone Neoplasm - Osteosarcoma

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®